חומצה קפרילית*

מקורות

1. Traul, K. A., Driedger, A., Ingle, D. L., and Nakhasi, D. Review of the toxicologic properties of medium-chain triglycerides. Food Chem Toxicol 2000;38(1):79-98.

2. Nair, M. K., Joy, J., and Venkitanarayanan, K. S. Inactivation of Enterobacter sakazakii in reconstituted infant formula by monocaprylin. J Food Prot. 2004;67(12):2815-2819.

3. McLay, J. C., Kennedy, M. J., Orourke, A. L., Elliot, R. M., and Simmonds, R. S. Inhibition of bacterial foodborne pathogens by the lactoperoxidase system in combination with monolaurin. Int J Food Microbiol. 2-25-2002;73(1):1-9.

4. Ikeda, I., Tomari, Y., Sugano, M., Watanabe, S., and Nagata, J. Lymphatic absorption of structured glycerolipids containing medium-chain fatty acids and linoleic acid, and their effect on cholesterol absorption in rats. Lipids 1991;26(5):369-373.

5. Han, J., Hamilton, J. A., Kirkland, J. L., Corkey, B. E., and Guo, W. Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats. Obes Res 2003;11(6):734-744.

6. Nagata, J., Kasai, M., Negishi, S., and Saito, M. Effects of structured lipids containing eicosapentaenoic or docosahexaenoic acid and caprylic acid on serum and liver lipid profiles in rats. Biofactors 2004;22(1-4):157-160.

7. Cappello, G., Malatesta, M. G., Ferri, A., Ciccaglione, A. F., Toracchio, S., Grossi, L., and Marzio, L. Gastric emptying of a solid-liquid meal measured with 13C octanoic acid breath test and real-time ultrasonography: a comparative study. Am J Gastroenterol 2000;95(11):3097-3100.

8. Ghoos, Y. F., Maes, B. D., Geypens, B. J., Mys, G., Hiele, M. I., Rutgeerts, P. J., and Vantrappen, G. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993;104(6):1640-1647.

9. Maes, B. D., Hiele, M. I., Geypens, B. J., Rutgeerts, P. J., Ghoos, Y. F., and Vantrappen, G. Pharmacological modulation of gastric emptying rate of solids as measured by the carbon labelled octanoic acid breath test: influence of erythromycin and propantheline. Gut 1994;35(3):333-337.

10. Van Den, Driessche M., Peeters, K., Marien, P., Ghoos, Y., Devlieger, H., and Veereman-Wauters, G. Gastric emptying in formula-fed and breast-fed infants measured with the 13C-octanoic acid breath test. J Pediatr Gastroenterol Nutr 1999;29(1):46-51.

11. Fischer, H. and Wetzel, K. The future of 13C-breath tests. Food Nutr Bull. 2002;23(3 Suppl):53-56.

12. Pfaffenbach, B., Wegener, M., Adamek, R. J., Wissuwa, H., Schaffstein, J., Aygen, S., and Hennemann, O. [Non-invasive 13C octanoic acid breath test for measuring stomach emptying of a solid test meal--correlation with scintigraphy in diabetic patients and reproducibility in healthy probands]. Z Gastroenterol 1995;33(3):141-145.

13. Schneider, A. R., Kraut, C., Lindenthal, B., Braden, B., Caspary, W. F., and Stein, J. Total body metabolism of 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men. Eur J Gastroenterol Hepatol 2005;17(11):1181-1184.

14. Haubenberger D., McCrossin G., Lunqu C., et al. Octanoic acid in alcohol responsive essential tremor: a randomized controlled study. Neurology, 2013; 80(10):933-40.

15. Huttenlocher, P. R., Wilbourn, A. J., and Signore, J. M. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 1971;21(11):1097-1103.

16. Trauner, D. A. Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology 1985;35(2):237-238.

17. Sills, M. A., Forsythe, W. I., Haidukewych, D., and et al. The medium chain trigylceride diet and intractable epilepsy. Arch Dis Child 1986;61:1168-1172.

18. Schwartz, R. H., Eaton, J., and Bower, B. D. Ketogenic diets in the treatment of epilepsy: short term clinical effects. Dev Med Child Neurol 1989;31:145-151.

19. Kinsman, S. L., Vining, E. P., Quaskey, S. A., Mellits, D., and Freeman, J. M. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 1992;33(6):1132-1136.

20. Vining, E. P. G., Freeman, J. M., Ballaban-Gill, and et al. A multi-center study of the efficacy of the ketogenic diet. Arch Neurol 1998;55:1433-1437.

21. Hopkins, I. J. and Lynch, B. C. Use of ketogenic diet in epilepsy in childhood. Aust Paediatr J 1970;6:25-29.

22. Janaki S, Rashid MK, and Gulati MS. A clinical, electroencephalographic correlation of seizures on a ketogenic diet. Indian J Med Res 1976;64:1057-1063.

23. Huttenlocher, P. R. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res 1976;10:536-540.

24. Berman, W. Medium chain triglyceride diet in the treatment of intractable childhood epilepsy. Dev Med Child Neurol 1978;20:249-225.

25. Haidukewych D., Forsythe WI., Sills M. Monitoring octanoic and decanoic acids in plasma from children with intractable epilepsy treated with medium chain triglyceride diet. Clin Chem. 1982 Apr28(4 Pt 1):642-5.

26. Wlaz P., Socala K., NIeocyzm D., et al. Anticonvulsant profile of caprylic acid, a main constituent of a medium-chain triglyceride (MCT) ketogenic diet, in mice. Neuropharmacology 2012;62(4):1882-9.

27. ECKMANN L., KAGNOFF M.F., FIERER J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect. Immun. 1993;61:4569–4574.

28. JEPPESEN P.B., MORTENSEN P.B. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut. 1998;43:478–483.

29. Neuhauser, I. Successful treatment of intestinal moniliasis with fatty acid-resin complex. AMA.Arch Intern Med 1954;93(1):53-60.

30. Omura Y., O'Young B., Jones M., Pallos A., Duvvi H., Shimotsuura Y. Caprylic acid in the effective treatment of intractable medical problems of frequent urination, incontinence, chronic upper respiratory infection, root canalled tooth infection, ALS, etc., caused by asbestos & mixed infections of Candida albicans, Helicobacter pylori & cytomegalovirus with or without other microorganisms & mercury. Acupunct Electrother Res. 2011;36(1-2):19-64

31. Aihiro Hoshimoto, Yasuo Suzuki, Tatsuro Katsuno, Hiroshi Nakajima, Yasushi Saito. Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. Br J Pharmacol. May 2002; 136(2): 280–286.

32. Liefaard, G., Heineman, E., Molenaar, J. C., and Tibboel, D. Prospective evaluation of the absorptive capacity of the bowel after major and minor resections in the neonate. J Pediatr Surg. 1995;30(3):388-391.

33. Kuhara, T., Matsumoto, I., Ohno, M., and Ohura, T. Identification and quantification of octanoyl glucuronide in the urine of children who ingested medium-chain triglycerides. Biomed Environ.Mass Spectrom. 1986;13(11):595-598.

34. Robinson, M. K. Population differences in acute skin irritation responses. Race, sex, age, sensitive skin and repeat subject comparisons. Contact Dermatitis 2002;46(2):86-93.

35. Sogorb, M. A., Carrera, V., and Vilanova, E. Hydrolysis of carbaryl by human serum albumin. Arch Toxicol. 2004;78(11):629-634.

36. Kristev, A., Mitkov, D., Lukanov, Y., and Chapkynov, P. The effect of octanoic fatty acid on the cardiovascular system of the guinea pig. Cor Vasa 1989;31(4):321-7

37. Giannakou, S. A., Dallas, P. P., Rekkas, D. M., and Choulis, N. H. In vitro evaluation of nimodipine permeation through human epidermis using response surface methodology. Int J Pharm 7-8-2002;241(1):27-34.

38. Massolini, G., Aubry, A. F., McGann, A., and Wainer, I. W. Determination of the magnitude and enantioselectivity of ligand binding to rat and rabbit serum albumins using immobilized-protein high performance liquid chromatography stationary phases. Biochem Pharmacol 10-5-1993;46(7):1285-1293.

39. Hayball, P. J., Holman, J. W., and Nation, R. L. Influence of octanoic acid on the reversible protein binding of ketorolac enantiomers to human serum albumin (HSA): comparative liquid chromatographic studies using a HSA chiral stationary phase. J Chromatogr B Biomed Appl 12-2-1994;662(1):128-133.

40. Noctor, T. A., Wainer, I. W., and Hage, D. S. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. J Chromatogr 6-10-1992;577(2):305-315.

41. Chabrol, B., Mancini, J., Bertrand, C., Vianey-Saban, C., Divry, P., Livet, M. O., and Pinsard, N. [Generalized epilepsy disclosing medium-chain-acyl-CoA dehydrogenase deficiency]. Arch Fr.Pediatr 1993;50(6):497-500.

42. Duran, M., Mitchell, G., de Klerk, J. B., de Jager, J. P., Hofkamp, M., Bruinvis, L., Ketting, D., Saudubray, J. M., and Wadman, S. K. Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. J Pediatr 1985;107(3):397-404.

43. Gregersen, N., Rosleff, F., Kolvraa, S., Hobolth, N., Rasmussen, K., and Lauritzen, R. Non-ketotic C6-C10-dicarboxylic aciduria: biochemical investigations of two cases. Clin Chim.Acta 3-28-1980;102(2-3):179-189.